VIENNA, Va., Dec. 14, 2000 (PRIMEZONE) -- Allied Research Corporation (AMEX:ALR), a diversified defense and commercial electronic security firm, said today that its defense unit, MECAR S.A., had received notice from The US Army that the Army's Operations Support Command had activated an existing contract option for MECAR's dual use fuze EPD 9013.
Mr. Glenn Yarborough, President and Chief Executive Officer of Allied Research, said: "We are pleased with the confidence the Army has placed in our ammunition. I expect this activated option, for $847,300, will be one of several that will be picked up in the months ahead. Our MECAR engineers met an extremely challenging design task that called for maximizing mortar ammunition performance while meeting and extending full safety requirements. The Army project personnel outlined their needs carefully and our people were able to meet the Army's demanding performance and safety specifications. The MECAR fuzes are fully tested under very demanding field conditions and I can confidently report that these fuzes are the key element in delivering top operational performance for the 120mm mortar."
The MECAR EPD 9013 fuze has been developed to take full advantage of the direct fire capability of the next generation of turreted mortars. It can engage targets in direct fire from 200 meters on, as well as perform all indirect fire missions. The EPD 9013 is an electronic point detonating fuze with two independent arming systems and super-quick or delay functions, depending on battlefield requirements. The fuze meets all MIL-STD-1316D safety criteria and the mortar ammunition round has received full Army safety certification.
Allied Research Corporation is a defense and commercial electronic security firm. Its operating units develop and produce ammunition. In addition, they design, product and market sophisticated commercial electronic security and access control systems.
Certain statements contained herein are "forward-looking" statements as such term is defined in the Private Securities Litigation Reform Act of 1995. Because statements include risks and uncertainties, actual results may differ materially from those expressed or implied, and include, but are not limited to, those discussed in filings by the Company with the Securities and Exchange Commission.
For additional information contact Susan Urbaniak -- 800-847-5322 or alrarc95@aol.com.